Pfizer
PFE
PFE
2,664 hedge funds and large institutions have $136B invested in Pfizer in 2020 Q4 according to their latest regulatory filings, with 312 funds opening new positions, 664 increasing their positions, 1,687 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,664
Holders Change
+164
Holders Change %
+6.56%
% of All Funds
47.27%
Holding in Top 10
64
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-37.25%
% of All Funds
1.14%
New
312
Increased
664
Reduced
1,687
Closed
110
Calls
$2.58B
Puts
$2.19B
Net Calls
+$399M
Net Calls Change
+$117M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$1.97B |
| 2 |
Citadel Advisors
Miami,
Florida
|
$218M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
$668M |
| 4 |
Bank of New York Mellon
New York
|
$2.38B |
| 5 |
O
OrbiMed
New York
|
$133M |
Top Sellers
| 1 |
BlackRock
New York
|
$14.6B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$16.5B |
| 3 |
State Street
Boston,
Massachusetts
|
$10.3B |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$149M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$2.52B |
